Clinical Trial Update: I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

View source ↗

Summary

This clinical trial update describes a study evaluating I-124 PET/CT imaging and dosimetry in thyroid cancer patients, including those who are radioactive iodin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rai-refractory Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Iodine-124 (Iodine-124)

Snippet

Sponsor: Miami Cancer Research Center, Inc. | Conditions: Thyroid Cancer, RAI-Refractory Thyroid Cancer | Status: RECRUITING